Value proposition

Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide therapeutics.

Meddenovo is advancing AI-driven drug discovery with a specialized technology platform designed specifically for cyclic peptides. Our platform can design cyclic peptides from scratch, even without prior experimental data, and incorporates cutting-edge technology to capture their chameleon-like properties, including cell permeability. This unique capability enables us to address previously undruggable targets with precision.

Cyclic peptides are a transformative class of compounds in pharmaceutical research, offering the advantages of both small molecules and large biologics, such as exceptional binding affinities, stability, and specificity. Technological advancements in the past decade have made peptides more accessible, and AI-driven companies like Meddenovo are now working to unlock their full potential to find cures for more diseases.

At Meddenovo, we are committed to precision and reliability in drug discovery. Our approach reduces failure rates and accelerates the journey from research to market, empowering scientists worldwide with advanced, user-friendly AI tools. By democratizing access to sophisticated drug discovery technologies, we enable a broader community to contribute to innovative treatments.

Discover how Meddenovo can transform your drug discovery process. With our advanced technologies and dedication to excellence, we are your partner in creating the next generation of medicines. Contact us today to learn more about custom access to our platform.